Trial intelligence / Profile preview

Lidocaine spray for pain relief during infusion port needle puncture

ChiCTR2300072976Phase 4Recruiting

Sponsor
Shanghai General Hospital
Start
Jan 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of lidocaine in procedural pain (2 arms), sponsored by Shanghai General Hospital. Primary endpoint: Pain intensity. Started Jan 2023; status: recruiting.

02

Drugs

lidocaine
03

Conditions

procedural pain

Beyond the preview

Go deeper on ChiCTR2300072976.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300072976.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call